This study describes the existence and the clinical and electrophysiological features of multi-focal cortical dysplasia in epilepsy patients. Five patients with intractable focal epilepsy are reported. All patients underwent invasive presurgical videoelectroencephalography monitoring. Localization of dysplastic areas was based on high-resolution magnetic resonance scanning, surface and intracranial electroencephalography. Four patients underwent epilepsy surgery. Histological findings in focal cortical dysplasia (FCD) were classified according to Palmini. In addition, genetic examinations were performed in order to assess possible mutations in the genes for tuberous sclerosis complex. In four patients, FCDs were located in the same hemisphere. One case presented with bilateral FCDs. In three patients seizures arose from two separate dysplastic areas and in one patient, one lesion showed only interictal activity. In one further patient, seizures started exclusively from the hippocampus. In two of three patients with removal of the FCDs, the histological subtype was identical (Palmini type 2) and in one patient, histology differed between the lesions. All operated patients became seizure-free. In patients with FCD type 2, germ-line mutations in the tuberous sclerosis complex genes were not detectable. Dysplastic brain regions may not be restricted to a single brain region. Areas of FCD can have different degrees of epileptogenicity, ranging from electrographic silence to interictal epileptic discharges and initial involvement in seizure generation. Based on genetic analysis and clinical features, multi-FCD in this patient series was not likely to be related to tuberous sclerosis.
Introduction
Focal cortical dysplasia (FCD) is generally considered as a circumscribed brain area which is characterized by abnormal cortical thickening and blurring of the grey-white matter boundary on high-resolution MR imaging (Chan et al., 1998; Bastos et al., 1999; Urbach et al., 2002) and histologically characterized by dyslamination with or without abnormal cytoarchitectonic elements (Palmini and Lü ders, 2002; Palmini et al., 2004) . The growing detection of FCD underlying formerly 'cryptogenic' pharmacoresistant focal epilepsy suggests a high intrinsic epileptogenicity (Palmini et al., 1995) . Increasing experience with FCD patients challenges the assumption of (uni)focality of FCD at least in a subset of patients.
Taylor and colleagues, who first described FCD in 1971 (Taylor et al., 1971) , already suggested that potentially epileptogenic FCD may be non-contiguous. They observed that within the limits of the resected lobes the abnormality was sometimes disseminated rather than confined to a single patch. Moreover, there are some clinical arguments supporting the idea of more widespread brain involvement of FCD: the postoperative outcome in patients with FCD is inferior to that of patients with hippocampal sclerosis or other unilocular pathologies like tumours, although more recent studies have shown an improvement of outcome (Chassoux et al., 2000; 2004; Fauser et al., 2004 Yun et al., 2006; Widdess-Walsh et al., 2007) . Not all FCD cases with presumed complete resection of the dysplastic area, according to MRI, become seizure-free (Palmini et al., 1995) , suggesting the presence of additional MRI occult pathology. Volumetric MRI studies give evidence for the existence of extensive structural disorganization outside visually identified focal lesions in patients with cortical dysgenesis. Voxel-based morphometry revealed grey matter excess, which extends to brain areas not visually defined as abnormal (Huppertz et al., 2005 (Huppertz et al., , 2008 Bonhila et al., 2006) .
In this study, we report ictal and interictal EEG findings, genetic examinations and surgical outcome in five cases with multi-FCD, shown overtly by MRI.
Patients and Methods

Patients
All patients presented here were referred to the Epilepsy Center of the University Hospital of Freiburg, Germany, between 2002 and for presurgical evaluation and epilepsy surgery due to pharmacoresistant epilepsy. Three of the investigated patients were female. The age at epilepsy onset ranged from 0 to 18 years (mean 5.6 years, median 0 years), and the age when invasive recordings/surgery was performed ranged from 7 to 41 years (mean 25.4 years, median 33 years).
MRI examinations
MRI scans were acquired either with 1.5 Tesla scanner (Siemens Magnetom Vision or Siemens Magnetom Symphony) or with a 3 Tesla scanner (Siemens Magnetom TRIO). The following sequences were performed: T 2 -weighted images (axial and coronal, varying slice thickness from 1 to 3 mm), fluid-attenuated inversion recovery (FLAIR) images (2-6 mm slice thickness) and T 1 -weighted MPRAGE (magnetization-prepared rapid gradient echo) 3D data sets (1 mm voxel size) with and without gadolinium-DTPA. Additionally, coronal and axial images were acquired with a modified angulation perpendicular or parallel to the long axis of the temporal lobe to evaluate the mesiotemporal structures.
MRI criteria suggestive for FCD were gyration anomalies, focal thickening of the cortex, blurring of the grey-white matter junction and abnormal cortical and subcortical signal intensity. In addition, MRI post-processing procedures (i.e. morphometric MRI analyses) were performed as described elsewhere (Huppertz et al., 2005 (Huppertz et al., , 2008 .
Histological examinations
In patients undergoing epilepsy surgery, excised tissue was fixed for 12-24 h in 10% buffered formalin, embedded in paraffin and sectioned. Staining was carried out using haematoxylin-eosin, periodic acid-Schiff (PAS) and Kluever-Barrera myelin stain. For selected cases, additional special stains (Elastica-van-Gieson, Reticulin, Bodian) were used. Additional immunohistochemical stainings were performed with antibodies against neurofilament and microtubule associated protein to visualize the orientation of neurons and to depict dysmorphic neurons or ectopic white matter neurons and against synaptophysin, another neuronal marker. Glial fibrillary acid protein (GFAP) and vimentin immunohistochemistry was performed in order to better visualize astrogliosis and/or balloon cells. Moreover, the proliferation marker Ki-67, the pan-leucocyte marker leucocyte common antigen (LCA) and the microglial marker CD 68 were applied.
Histological dysplastic features were classified as suggested by Palmini (Palmini and Lü ders, 2002) : isolated architectural abnormalities (dyslamination) (FCD 1a), additional 'immature neurons' or giant neurons (FCD 1b), additional dysmorphic neurons (FCD 2a) and additional balloon cells (FCD 2b) .
In two patients undergoing hippocampal resection, histological grading of hippocampal pathology was classified according to Wyler et al. (1995) and Blü mcke et al. (2007) .
EEG recordings
All patients first underwent surface video-EEG monitoring. Since the results were inconclusive concerning localization and/or extension of the seizure onset zone, additional invasive video-EEG monitoring with subdural and/or depth electrodes was performed. The localization of invasive electrodes is depicted in Figs 1-5 for cases 1-5.
Genetic analyses
Surgical specimens were fixed overnight in formaldehyde and embedded in paraffin. DNA isolation from paraffin embedded tissue and blood was carried out with QIAamp DNA MiniKit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. Amplification was performed by PCR in an automated thermocycler (Gradienten Cycler, T-Gradient 96, Biometra, Gö ttingen, Germany). Primer combinations were used as described previously (Becker et al., 2002) . Single strand conformation polymorphism (SSCP) analyses were performed to detect aberrant allelic distribution, and DNA was visualized by silver staining, according to standard protocols described elsewhere (Bender et al., 1996) . Sequencing was performed if aberrant allelic distribution was visible in SSCP. The sequencing was performed in a MegaBace 500 Sequencer at the 'Core Facility' of the University of Freiburg. The visualization was carried out by the program 'Chromas Version 1.45'. The base sequences were compared with data obtained from the National Centre of Biotechnology Information (NCBI) (TSC1 gene AL445645.10, TSC2 gene AC005600.1). In one patient (Case 5) genetic analyses as to TSC was performed by the Institute for Human Genetics of the University of Mü nster, Germany.
Postoperative follow-up
Follow-up data were collected at 3-month intervals in the first year and annually in the ensuing years, in all patients. Surgical outcome was classified according to Engel and Rasmussen (1993) : (ia) completely seizure free; (i) seizure free or auras only or convulsions with drug withdrawal only; (ii) rare seizures (42 seizures/year or 590% seizure reduction); (iii) reduction of seizure frequency 575%; and (iv) reduction of seizure frequency 575%.
Case reports
Clinical characteristics of patients with multi-FCDs are summarized in Table 1 .
Case 1
This female patient has no family history of epilepsy. Pregnancy and delivery were reported as normal. First seizures occurred at the age of 9 months. The epilepsy was pharmacoresistant from the very beginning. MRI showed two areas of FCD: (i) left temporo-occipital; and (ii) left parietal (transmantle dysplasia) (Figs 1A and B) . Based on surface EEG, all recorded seizures arose from left temporo-occipital or occipital areas. The maximum interictal activity was also seen left temporo-occipitally. However, there was a second interictal focus (left centro-parietal) in the region of the other dysplasia, so that a second independent seizure onset zone could not be excluded.
The patient underwent invasive video-EEG monitoring. Seizure semiology consisted of a series of simple partial myoclonic twitching of her right hemi-face, atonic seizures and complex partial seizures with oral automatisms, followed by tonic posturing of the whole body and bilateral limb clonus. The patient was implanted with a subdural grid electrode and subdural strip electrodes covering both lesions (Fig. 1) . Twenty-one series of simple partial myoclonic seizures were recorded. Seizure onset was simultaneously seen over both dysplastic areas in the majority of seizures (Fig. 1C ). In few seizures and interictally the temporal contacts seemed to lead (not shown). Language mapping was performed and language was not detectable in the left temporal lobe.
Based on these recordings, both dysplastic areas were regarded as epileptogenic and removed surgically (temporal: extended lesionectomy, parietal: lesionectomy). The patient has remained seizure-free for 3 years. She had no postoperative neurological deficits. Histology showed FCD type 2b left temporo-posterior ( Fig. 1E ) and FCD 1b in the adjacent temporo-anterior area (which was inconspicuous based on MRI criteria) (Fig. 1D ). There was no clear histological evaluation of parietal tissue as the resected specimen was small and fragmented; however, the MRI finding of a transmantle dysplasia suggests that this lesion was also an FCD type 2 Krsek et al., 2008) . The patient had no extracerebral clinical manifestations of tuberous sclerosis at the time of epilepsy surgery. A genetic examination gave no evidence for mutations in the TSC1 and TSC2 genes.
Case 2
This female patient has a positive family history of epilepsy (her mother, the brother of her mother and a cousin on the mother's side suffered from epilepsy). Pregnancy and delivery were normal. First seizures occurred at the age of 8 months. The epilepsy remained pharmacoresistant throughout the course of disease. MRI showed two dysplastic areas: (i) in the right anterior temporal neocortex extending to the right amygdala ( Fig. 2A and B) ; and (ii) in the right frontomesial cingulate gyrus ( Fig. 2C and D) . In addition, a mild hippocampal sclerosis was suspected, based on slightly reduced hippocampal volume and discrete hyperintensity. Surface EEG was not sufficient to determine the seizure onset zone, as no ictal activity was observable at the time of clinical seizure onset. During the later part of seizures, 60 s after seizure onset, bifronto-temporal rhythmic theta activity was discernible. Interictally, sharp waves were observed bitemporally and bifrontally with a right sided maximum. At the age of 11 years, the patient underwent invasive video-EEG monitoring. Seizure semiology consisted of nocturnal proximal limb movements accompanied by vocalization, sometimes preceded by a feeling of panic. The patient was implanted with subdural strip electrodes covering both lesions (Fig. 2) . During monitoring, eight seizures were captured. In seven seizures, onset of ictal activity was recorded over the right frontal lesion or simultaneously over both lesions (Fig. 2E) . In one seizure, ictal activity started over the temporal lesion only (not shown). Both lesions were surgically removed (tailored lesionectomy right frontally and right 2/3 temporal lobe resection with amygdalohippocampectomy). The patient has remained seizure-free for 3 years. She had no postoperative neurological deficits. Histology showed FCD 2a in both dysplastic areas (Fig. 2F) 
Case 3
This male patient has a positive family history of epilepsy (one brother of his father suffered from epilepsy). Pregnancy and delivery were normal. First seizures occurred at the age of 5 months. The epilepsy remained pharmacoresistant throughout the course of the disease. MRI gave evidence of two lesions: (i) visual inspection showed a large area with cortical thickening and cortical-subcortical blurring in the left temporal lobe; and (ii) MRI post-processing with voxelbased morphometry additionally revealed an area of blurred greywhite matter transition suggestive for FCD in the left basal frontal lobe (Fig. 3A-D) . Whereas surface EEG showed left temporal (and less frequently also right temporal) interictal spiking and a left temporal seizure onset, semiology (see below) suggested frontal lobe seizures.
At the age of 33 years, the patient underwent invasive video-EEG monitoring. Seizure semiology consisted of nocturnal hypermotor complex partial seizures. The patient was implanted with a depth electrode in the left hippocampus, and left temporal and frontal subdural strip electrodes (Fig. 3) . During monitoring, more than 100 seizures were recorded. Seizure onset was always observed over the left temporal dysplasia (Fig. 3E) . Interictally, there was an almost continuous and independent focus characterized by a repetitive bursting pattern or a rhythmic spiking pattern in the fronto-basal region (not shown) (Boonyapisit et al., 2003; Fauser and Schulze-Bonhage, 2006) . The patient underwent extended temporal lobe resection and additional lesionectomy in the basal frontal lobe. Postoperatively, the patient has remained seizure-free for 3 years. He had no postoperative neurological deficits. Histology obtained from specimens of both areas showed FCD 2b ( Fig. 3F and G) . The patient had no extracerebral clinical manifestations of tuberous sclerosis at the time of epilepsy surgery. A genetic examination for mutations in the TSC1 and TSC2 gene was negative.
Case 4
This male patient has no family history of epilepsy. First seizures occurred at the age of 11 years. The epilepsy remained intractable. MRI showed right hippocampal sclerosis with volume loss and signal hyperintensity, and additional areas suggestive for FCD in the right superior frontal gyrus as well as in the right temporo-occiptal region ( Fig. 4A and B) . Interictal surface EEG showed continuous right temporal slowing and intermittent bitemporal epileptiform discharges. At the age of 35 years, the patient underwent invasive video-EEG monitoring. Seizure semiology consisted of epigastric auras sometimes evolving into complex partial automotor seizures. The patient was implanted with a right hippocampal depth electrode and subdural strip electrodes over the dysplastic lesions (Fig. 4) . During the monitoring, 24 seizures were recorded. In all of these seizures, first ictal activity was seen in the hippocampus (Fig. 4C) . Spread of ictal activity to the dysplastic lesions was always observed, but relatively late in the course of the seizure (30-130 s after EEG seizure onset). Based on these intracranial EEG findings, the patient underwent a selective amygdalohippocampectomy. He has remained seizure-free for 3 years. No neurological sequelae were observed. Histology showed hippocampal sclerosis Grade 3 according to Wyler/MTS type 1a according to Blü mcke. The patient had no extracerebral clinical manifestations of tuberous sclerosis at the time of epilepsy surgery.
A genetic examination for mutations in the TSC1 and TSC2 genes was negative.
Case 5
This female patient has a positive family history of epilepsy (her brother suffers from epilepsy). Pregnancy and delivery were reported as normal. First seizures occurred presumably at the age of 18 years. The epilepsy remained pharmacoresistant against several antiepileptic drugs. MRI showed three areas strongly suggesting cortical dysplasia: (i) in the right frontal lobe (Fig. 5A) ; (ii) in the left insular region (Fig. 5C and D) ; and (iii) in the right temporo-parietal area ( Fig. 5F and G). In the surface EEG, no ictal activity was discernible at seizure onset, only in one subclinical seizure a left temporal rhythmic activity was registered. Interictal spikes or sharp waves very rarely occurred over the left temporal and right frontal lobe.
At the age of 41 years, the patient underwent invasive video-EEG monitoring. Seizure semiology was characterized by an initial fear, tachycardia and a flush, followed by manual automatisms and tonic posturing alternatively of the right and left arm. She was stereotactically implanted with depth electrodes in all of the three dysplastic areas (Figs 5B, E and H) . During the monitoring, in 5 of 14 seizures ictal onset was seen in the left insular dysplasia (Fig. 5I) , eight seizures arose simultaneously from the left insular and right temporo-parietal dysplasia, and in one seizure, ictal onset was observed in the right temporo-parietal lesion only (not shown). No seizure onset was observed in the right frontal lobe. Surgery was not performed in this patient. The patient had no extracerebral clinical manifestations of tuberous sclerosis at the time of presurgical evaluation. A genetic examination for mutations in the TSC1 and TSC2 genes was negative.
Discussion
In this study, we report a series of five patients with MRI evidence for multi-FCD, supported by histology in three cases that were operated on. These patients represent a particularly interesting group, regarding both pathogenetic mechanisms and epileptogenic potential of cortical dysplasia. The pathogenetic mechanisms underlying FCD are unclear. Genetic or environmental factors could be responsible for the development of FCD. In particular, a possible relationship with the tuberous sclerosis complex (TSC) is of interest, as TSC is characterized by multiple dysplastic brain areas (tubers) showing To indicate more clearly the area of seizure onset, the invasive electrodes are shown, contacts with seizure onset are marked by red dots. (E) Example of an invasive EEG recording (bipolar derivation, 30 mV/mm, 0.1 s, 120 Hz) at the beginning of a hypermotor complex partial seizure with an onset from the temporal lesion. The red arrow indicates EEG seizure onset in terms of a high frequent activity at the left temporo-posterior area (electrode contacts TBC4-6 and G A4-8). (F and G) depict histological features of a FCD 2b seen in both lesions: (F) large and irregular dysmorphic neurons (neurofilament immunostaining) and (G) balloon cells in the subcortical white matter (haematoxylineosin staining). similar histology to FCD type 2b. In our study, no germ-line mutations in the TSC1 or TSC2 gene could be detected. According to Roach et al. (1998) , clinical criteria for a definitive diagnosis of TSC require two or more distinct types of lesions, rather than multiple lesions of the same type in the same organ system. However, none of the patients in our study had subependymal nodules which are seen in 95% of patients with TSC (O'Callaghan, 2008) or extracerebral manifestations of tuberous sclerosis on clinical examination verified by dermatological examination including the use of Wood's light, fundoscopy, echocardiography and renal ultrasound. Reports on TSC without extracerebral manifestations are rare. A computed tomography-based study in patients with tuberous sclerosis was published in 1986, describing positive radiological and negative extracerebral clinical features in 16% of 110 patients (Kingsley et al., 1986) . Whereas in other malformations of the cortical development a multi-focal appearance has frequently been described (e.g. polymicrogyria, pachygyria) (Raymond et al., 1995) , only one patient with three cortical dysplasias shown by MRI has been reported in the literature so far. However, in this patient no genetic analysis has been described (Yagishita and Arai, 1999) . Our study cannot completely exclude clone-or cell-type restricted (somatic) gene changes. However, three of five patients with multi-FCD have a positive family history of epilepsy which could be an argument against a clone-or cell-type restricted somatic gene change and in favour of a familial predisposition. Information on the aetiology of epilepsy in the relatives was not available.
Three of five patients underwent surgical removal of the dysplastic tissue, and histology confirmed FCD type 2 according to Palmini and Lü ders (2002) and Palmini et al. (2004) in all but one available specimen. In Case 1, histology was not available from the parietal lesion. The MRI finding of a transmantle dysplasia ( Fig. 1E and F) , however, is suggestive of a FCD type 2, as observed in the temporal specimen of the same patient. The identity of histological subtypes in both lesions of these patients hints to a similar point in time for the development of both lesions within one and the same patient. It could be speculated whether the predominance of FCD type 2 in this series of patients with multi-FCD is related to presurgical patient selection due to a better visualization of FCD type 2 on MRI compared to FCD type 1 or whether this predominance is intrinsically linked to the aetiology of this disease. Moreover, it remains open if the different lesions are connected by microscopic pathways that MRI cannot identify.
Epileptogenicity of these lesions was highly variable. In three of five invasively recorded patients, seizure onset from two different dysplastic areas could be proven (Cases 1, 2 and 5). In one patient (Case 3), however, the second dysplastic lesion showed only interictal activity during the period of invasive video-EEG recording. This lesion, interestingly, was not visible on MRI. In one patient (Case 4), seizures only arose from the sclerotic hippocampus, but not from the dysplastic areas evident on magnetic resonance imaging. The high variability in epileptogenicity of these lesions may explain why some patients with FCD become seizure-free despite an incomplete resection of the lesion (Sisodiya, 2002) and why others do not become seizure-free although all dysplastic tissue visible on MR imaging was removed (Spreafico et al., 1998) . Case 3 demonstrates that dysplastic areas could be occult on conventional MRI and only detectable by post-processing procedures of MRI data (Huppertz et al., 2008) . The apparently simultaneous seizure onset in two lesions, as seen in Cases 1, 2 and 5, could either be explained by a tight network with very fast propagation of ictal activity as may be suggested in cases 1 and 2 who remained seizure-free postoperatively, or by a further MRI-occult epileptic region as supposed in Case 5, based on simultaneous seizure onset in both hemispheres.
Cases 1-3 show that surgical removal of two separate dysplastic lesions can result in long-lasting seizure-freedom. Thus, epilepsy surgery should be considered as an option in pharmacoresistant epilepsy even if multi-focality is suspected, based on EEG and/or MRI. Case 4, in whom only the hippocampus generated seizures, supports the view that multi-focal lesions do not preclude successful epilepsy surgery, if the epileptogenicity of lesions is properly assessed and resection is planned accordingly. Moreover, this case shows that several lesions need not necessarily function in a hierarchical fashion (Awad et al., 1991) , supposing that the removal of a dominant 'pacemaker' leads to seizure onset from formerly entrained epileptogenic foci. Seizure-freedom in all patients with multi-FCD undergoing epilepsy surgery suggests a better outcome than the postoperative results in patients with multi-lobar contiguous FCD. Multi-lobar extent of FCD has been reported as a negative predictor for postoperative seizure freedom, only 30%-40% of patients reaching Engel class I outcome postoperatively (Kloss et al., 2002; Fauser et al., 2004 Fauser et al., , 2008 . It is obvious that patients with multi-focal dysplasia need extensive presurgical evaluation. This has recently been reviewed in patients with epilepsy due to tuberous sclerosis (Madhavan et al., 2007; Jansen et al., 2007) . In none of our patients, with multi-FCD, was surface EEG sufficient to differentiate between the multiple dysplastic areas concerning seizure onset. In summary, despite the possible multi-focality of epileptogenesis, patients undergoing detailed presurgical evaluation have good chances for long-term seizure control after epilepsy surgery.
